COMPANY
CHONGQING CHEN'AN BIOPHARMACEUTICAL CO LTD
CHONGQING CHEN'AN BIOPHARMACEUTICAL CO LTD: API manufacturer for Insulin degludec, Liraglutide, Semaglutide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Insulin degludec | DMF 39910, type II, active, submitted 2024-06-28 Regulator FDA drug master file list |
|---|---|
| Liraglutide | DMF 38681, type II, active, submitted 2023-08-21 Regulator FDA drug master file list |
| Semaglutide | DMF 38798, type II, active, submitted 2023-09-20 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.